Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sphere of biopharmaceuticals, offering promising improvements throughout different healthcare and industrial purposes. With its structural similarity to Normally derived human serum albumin, OsrHSA provides a safer, a lot more trustworthy option for therapeutic